Cargando…

Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer

Background: Dipeptidyl peptidase-4 (DPP4), a cell surface protein, exhibits a crucial role in tumor biology and regulation of the immune system. We aim to study the impact of DPP4 inhibitors (DPP4i) in patients with prostate cancer (PRC), pancreatic cancer (PC) and breast cancer (BC). Methods: Using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Chintan, Hong, Young-Rock, Bishnoi, Rohit, Ali, Azka, Skelton, William Paul, Dang, Long H., Huo, Jinhai, Dang, Nam H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136489/ https://www.ncbi.nlm.nih.gov/pubmed/32296640 http://dx.doi.org/10.3389/fonc.2020.00405

Ejemplares similares

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study
por: Bishnoi, Rohit, et al.
Publicado: (2019)

Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
por: Skelton, William P, et al.
Publicado: (2019)

A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer
por: Pan, Kelsey, et al.
Publicado: (2021)

Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer
por: Nguyen, Thu-Cuc, et al.
Publicado: (2018)

A Single-center Retrospective Analysis of the Effect of Radium-223 (Xofigo) on Pancytopenia in Patients with Metastatic Castration-resistant Prostate Cancer
por: Skelton, William P, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients
por: Bishnoi, Rohit, et al.
Publicado: (2017)

A Novel Case of Penile Gangrene in a Patient Treated with Ibrutinib for Chronic Lymphocytic Leukemia
por: Skelton IV, William Paul, et al.
Publicado: (2016)

Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas
por: Ren, Chao, et al.
Publicado: (2022)

Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress
por: Fadzeyeva, Evgenia, et al.
Publicado: (2023)

Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study
por: Chou, Chu-Lin, et al.
Publicado: (2022)

Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic Immunosuppression
por: Turcotte, Madeleine E, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
por: Liu, Jinglong, et al.
Publicado: (2014)

A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma
por: Zhang, Chuan, et al.
Publicado: (2021)

Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019
por: Shu, Lingling, et al.
Publicado: (2021)

Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction
por: Gonzalez, Jimmy, et al.
Publicado: (2023)

DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma
por: Ke, Yumin, et al.
Publicado: (2022)

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies
por: Kikuchi, Shohei, et al.
Publicado: (2023)

PARP Inhibitors in Prostate and Urothelial Cancers
por: Garje, Rohan, et al.
Publicado: (2020)

PARP inhibitors in metastatic prostate cancer
por: Taylor, Amy K., et al.
Publicado: (2023)

Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis
por: Wang, Wenyi, et al.
Publicado: (2023)

DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells
por: Yuan, Weijie, et al.
Publicado: (2021)

Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS–NF-кB–NLRP3 Axis
por: Li, Rui, et al.
Publicado: (2021)

DPP8 is a novel therapeutic target for multiple myeloma
por: Sato, Tsutomu, et al.
Publicado: (2019)

Extraosseus Ewing's Sarcoma in Pancreas: A Review
por: Patel, Dharti, et al.
Publicado: (2020)

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials
por: Shah, Chintan, et al.
Publicado: (2018)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

The Effect of Payer Status on Survival of Patients With Prostate Cancer
por: Suh, Winston, et al.
Publicado: (2021)

Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non–Small Cell Lung Cancer: A Meta-Analysis
por: Li, Sihan, et al.
Publicado: (2021)

Anaplastic Carcinoma of the Pancreas: A Rare Clinical Entity
por: Oymaci, Erkan, et al.
Publicado: (2017)

Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer
por: Zhang, Wenqing, et al.
Publicado: (2021)

Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation
por: Hu, Feixiang, et al.
Publicado: (2022)

Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Radiotherapy plus immune checkpoint inhibitor in prostate cancer
por: Li, Tianjie, et al.
Publicado: (2023)

Genomic Alteration Burden in Advanced Prostate Cancer and Therapeutic Implications
por: Ryan, Matthew J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_shqk1lt0ikgdfd85avalpqofi7